AI predicts the likelihood of finding antidepressant helpful
New Scientist - 10-Feb-2020If developed, new research could help to improve the quality of mental disease treatments
Join the club for FREE to access the whole archive and other member benefits.
Developing a new generation of brain biomarker-based diagnostic tests and personalized treatments
Alto Neuroscience is a private company headquartered in Los Altos, CA. Alto is developing a new generation of biomarker-based diagnostic tests and personalized treatments for use in mental health, based on a platform built from data aggregated at scale and proprietary artificial intelligence analysis tools. The team combines world-leading neuroscientists and business executives with experience commercializing products for the brain.
Visit website: https://www.altoneuroscience.com/
See also: Amit Etkin - Professor of Psychiatry and Behavioral Sciences at Stanford University
Details last updated 16-Feb-2020
If developed, new research could help to improve the quality of mental disease treatments